Elanco Animal Health Inc
ELAN22.305USD
+0.215+0.97%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
11.08BMarket Cap
308.38P/E TTM
Elanco Animal Health Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
4.44B
0.50%
EPS(YoY)
0.68
127.36%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its total revenue reached 4.44B, with a year-on-year change of 0.50%.
What is the Earnings Per Share (EPS) of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 0.684, with a year-on-year change of 127.36%.
What is the net income of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its net income was 338.00M, with a year-on-year change of 127.46%.
What is the net margin of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its net profit margin was 7.61%, with a year-on-year change of 127.32%.
What is the gross margin of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its gross margin was 43.01%, with a year-on-year change of -1.98%.
What is the debt-to-asset ratio of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its debt-to-asset ratio was 34.26%, with a year-on-year change of -14.79%.
What is the Return on Equity (ROE) of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its Return on Equity (ROE) was 5.49%, with a year-on-year change of 130.12%.
What is the Return on Assets (ROA) of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its Return on Assets (ROA) was 2.51%, with a year-on-year change of 130.39%.
What is the operating profit of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its operating profit was 251.00M, with a year-on-year change of -23.01%.
What are the current assets of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its current assets were 3.21B, with a year-on-year change of -5.64%.
What are the total assets of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its total assets of Elanco Animal Health Inc were 12.61B, with a year-on-year change of -12.17%.
What are the total liabilities of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its total liabilities of Elanco Animal Health Inc were 6.52B, with a year-on-year change of -19.92%.
What is the total equity of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its total equity of Elanco Animal Health Inc was 6.10B, with a year-on-year change of -2.04%.
What is the net operating income of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its net operating income of Elanco Animal Health Inc was 338.00M, with a year-on-year change of 127.46%.
What is the net investment of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its net investment of Elanco Animal Health Inc was 1.16B, with a year-on-year change of 785.21%.
What is the net financing of Elanco Animal Health Inc?
According to Elanco Animal Health Inc's FY2024 earnings report, its net financing of Elanco Animal Health Inc was -1.49B, with a year-on-year change of -1697.59%.
